201 related articles for article (PubMed ID: 16934801)
1. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
[TBL] [Abstract][Full Text] [Related]
2. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
Morrison AA; Venables JP; Dellaire G; Ladomery MR
Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
[TBL] [Abstract][Full Text] [Related]
3. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
Yang C; Romaniuk PJ
Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
[TBL] [Abstract][Full Text] [Related]
4. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
[TBL] [Abstract][Full Text] [Related]
5. Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells.
Burwell EA; McCarty GP; Simpson LA; Thompson KA; Loeb DM
Oncogene; 2007 May; 26(23):3423-30. PubMed ID: 17160023
[TBL] [Abstract][Full Text] [Related]
6. Modulation of alternative pre-mRNA splicing in vivo by pinin.
Wang P; Lou PJ; Leu S; Ouyang P
Biochem Biophys Res Commun; 2002 Jun; 294(2):448-55. PubMed ID: 12051732
[TBL] [Abstract][Full Text] [Related]
7. A cell-autonomous role for WT1 in regulating Sry in vivo.
Bradford ST; Wilhelm D; Bandiera R; Vidal V; Schedl A; Koopman P
Hum Mol Genet; 2009 Sep; 18(18):3429-38. PubMed ID: 19549635
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and characterization of the 4 zinc finger region of human tumor suppressor WT1.
Nurmemmedov E; Thunnissen M
Protein Expr Purif; 2006 Apr; 46(2):379-89. PubMed ID: 16343939
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
10. HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.
Li H; Hou S; Hao T; Azam S; Liu C; Shi L; Lei H
RNA Biol; 2015; 12(12):1364-71. PubMed ID: 26512748
[TBL] [Abstract][Full Text] [Related]
11. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
[TBL] [Abstract][Full Text] [Related]
12. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
[TBL] [Abstract][Full Text] [Related]
14. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes.
Davies RC; Calvio C; Bratt E; Larsson SH; Lamond AI; Hastie ND
Genes Dev; 1998 Oct; 12(20):3217-25. PubMed ID: 9784496
[TBL] [Abstract][Full Text] [Related]
15. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
Ullmark T; Montano G; Gullberg U
Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
Oji Y; Tatsumi N; Kobayashi J; Fukuda M; Ueda T; Nakano E; Saito C; Shibata S; Sumikawa M; Fukushima H; Saito A; Hojo N; Suzuki M; Hoshikawa T; Shimura T; Morii E; Oka Y; Hosen N; Komatsu K; Sugiyama H
Mol Carcinog; 2015 Dec; 54(12):1758-71. PubMed ID: 25418835
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway.
Ito K; Oji Y; Tatsumi N; Shimizu S; Kanai Y; Nakazawa T; Asada M; Jomgeow T; Aoyagi S; Nakano Y; Tamaki H; Sakaguchi N; Shirakata T; Nishida S; Kawakami M; Tsuboi A; Oka Y; Tsujimoto Y; Sugiyama H
Oncogene; 2006 Jul; 25(30):4217-29. PubMed ID: 16518414
[TBL] [Abstract][Full Text] [Related]
18. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U
Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989
[TBL] [Abstract][Full Text] [Related]
19. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.
Kohsaka T; Tagawa M; Takekoshi Y; Yanagisawa H; Tadokoro K; Yamada M
Hum Mutat; 1999; 14(6):466-70. PubMed ID: 10571943
[TBL] [Abstract][Full Text] [Related]
20. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]